scienceneutral
Exploring a New Tool for Drug Discovery: The Power of Immobilized Human Serum Albumin
Thursday, January 16, 2025
The team behind this tool noticed that previous research wasn't very clear about the quality of HSA used for these tests. So, they decided to study different types of HSA and how well they hold onto medicines. They found that some types of HSA were better at this than others. They also discovered that using certain linkers, like glutardialdehyde (GDA) or cyclohexyl-diglycidyl ether (CDGE), to stick HSA to the magnetic nanoparticles worked really well. The HSA stuck to the magnetic nanoparticles with CDGE even held onto medicines better. However, they noticed that the HSA's ability to act like a tiny enzyme, called esterase-like activity, went down a bit.
This new tool could be a game-changer in the early stages of drug discovery. It helps scientists quickly and easily test how well new medicines stick to HSA. This could lead to better medicines in the future.
Actions
flag content